KANEKA Your partner in the world of Chirality!
.C0 2 H
OH
I
C0 2 H
I HorBz (RandS)
C0 2 H
NH 2 (RandS)
A n d T h e i r Derivatives KANEKA, a technologically versatile company, leading the global chiral marketplace. Providing customers with solid foundations to support new product development from laboratory and pilot plant t o full commercialization through process innovation. Technologies • Biotransformations, Biotechnologies • Organic chemistry Manufacturing From kg to 1,000's MT • Plants for bioprocesses and chemical reactions • Multi-purpose plants and dedicated plants • Penems & Carbapenems # ACE Inhibitor Intermediates • H M G C o . A Reductase Inhibitor Intermediates · A n t i - A I D S Drugs Intermediates • D - A m i n o acids · C h i r a l S y n t h o n s Kaneka Corporation
Kaneka America Corporation
Kaneka Pharma Europe N.V.
Fine Chemicals Division
Pharmaceuticals Division
Triomflaan 173
3-2-4, Nakanoshima Kita-Ku
65 East 55th Street
1160 Brussel, Belgium
Osaka 530-8288,Japan
N e w York, N.Y. 10022
Tel:
02-663-0340
Tel:
06-226-5142
Tel:
212-705-4340
Fax:
02-663-0361
Fax:
06-226-5128
Fax:
212-705-4350
[email protected] [email protected] [email protected] www.kaneka.co.jp/finechem/ © Kaneka Corporation
CIRCLE 2 1 ON READER SERVICE CARD
Quality Assurance •GMP • Many DMF's filed • Producing pharmaceutical bulk & intermediates
Κ3ΠΕΚ3